Liver TransplantationPub Date : 2024-10-01Epub Date: 2024-05-08DOI: 10.1097/LVT.0000000000000392
Thomas D Schiano, Daniel Ganger
{"title":"The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change.","authors":"Thomas D Schiano, Daniel Ganger","doi":"10.1097/LVT.0000000000000392","DOIUrl":"10.1097/LVT.0000000000000392","url":null,"abstract":"","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"1072-1077"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2024-10-01Epub Date: 2024-05-13DOI: 10.1097/LVT.0000000000000395
Tarunjeet Klair, Danielle Fritze, Glenn Halff, Ronit Patnaik, Elizabeth Thomas, Gregory Abrahamian, Jonathan M Cullen, Francisco Cigarroa
{"title":"Liver paired exchange: A US single-center experience-Pairs, chains, and use of compatible pairs.","authors":"Tarunjeet Klair, Danielle Fritze, Glenn Halff, Ronit Patnaik, Elizabeth Thomas, Gregory Abrahamian, Jonathan M Cullen, Francisco Cigarroa","doi":"10.1097/LVT.0000000000000395","DOIUrl":"10.1097/LVT.0000000000000395","url":null,"abstract":"<p><p>In the United States, the discrepancy between organ availability and need has persisted despite changes in allocation, innovations in preservation, and policy initiatives. Living donor liver transplant remains an underutilized means of improving access to timely liver transplantation and decreasing waitlist mortality. Liver paired exchange (LPE) represents an opportunity to overcome living donor liver transplant pair incompatibility due to size, anatomy, or blood type. LPE was adopted as a strategy to augment access to liver transplantation at our institution. Specific educational materials, consent forms, and selection processes were developed to facilitate LPE. From 2019 through October 2023, our center performed 11 LPEs, resulting in 23 living donor liver transplant pairs. The series included several types of LPE: those combining complementary incompatible pairs, the inclusion of compatible pairs to overcome incompatibility, and the use of altruistic nondirected donors to initiate chains. These exchanges facilitated transplantation for 23 recipients, including 1 pediatric patient. LPE improved access to liver transplantation at our institution. The ethical application of LPE includes tailored patient education, assessment and disclosure of exchange balance, mitigation of risk, and maximization of benefit for donors and recipients.</p>","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"1013-1025"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140898463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2024-10-01Epub Date: 2024-07-23DOI: 10.1097/LVT.0000000000000442
Therese Bittermann, Elena Byhoff
{"title":"CON: Satellite clinics are a marketing tool and do not improve access and equity in liver transplantation.","authors":"Therese Bittermann, Elena Byhoff","doi":"10.1097/LVT.0000000000000442","DOIUrl":"10.1097/LVT.0000000000000442","url":null,"abstract":"","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"1082-1085"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2024-10-01Epub Date: 2024-07-03DOI: 10.1097/LVT.0000000000000430
Kevin Pak, Sammy Saab
{"title":"\"Winning the peace\" against obesity in recipients of liver transplant.","authors":"Kevin Pak, Sammy Saab","doi":"10.1097/LVT.0000000000000430","DOIUrl":"10.1097/LVT.0000000000000430","url":null,"abstract":"","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"979-981"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2024-10-01Epub Date: 2024-04-23DOI: 10.1097/LVT.0000000000000375
Lauren C Y Tang, John D Chetwood, Mandy S M Lai, Terry C F Yip, Rena Cao, Elizabeth Powter, Shirin Salimi, Rodger Wu, Andrew Coulshed, David G Bowen, Simone I Strasser, Talal Valliani, Michael Crawford, Carlo Pulitano, Catriona McKenzie, James Kench, Geoffrey W McCaughan, Ken Liu
{"title":"Incidence, epidemiology, and outcomes of acute allograft rejection following liver transplantation in Australia.","authors":"Lauren C Y Tang, John D Chetwood, Mandy S M Lai, Terry C F Yip, Rena Cao, Elizabeth Powter, Shirin Salimi, Rodger Wu, Andrew Coulshed, David G Bowen, Simone I Strasser, Talal Valliani, Michael Crawford, Carlo Pulitano, Catriona McKenzie, James Kench, Geoffrey W McCaughan, Ken Liu","doi":"10.1097/LVT.0000000000000375","DOIUrl":"10.1097/LVT.0000000000000375","url":null,"abstract":"<p><p>Acute allograft rejection is a well-known complication of liver transplantation (LT). The incidence, epidemiology, and outcomes of acute rejection have not been well described in Australia. We retrospectively studied consecutive adults who underwent deceased donor LT at a single center between 2010 and 2020. Donor and recipient data at the time of LT and recipient outcomes were collected from a prospective LT database. Liver biopsy reports were reviewed, and only a graft's first instance of biopsy-proven acute rejection was analyzed. During the study period, 796 liver transplants were performed in 770 patients. Biopsy-proven rejection occurred in 34.9% of transplants. There were no significant changes in the incidence of rejection over time (linear trend p =0.11). The median time to the first episode of rejection was 71 days after LT: 2.2% hyperacute, 50.4% early (≤90 d), and 47.5% late rejection (>90 d). Independent risk factors for rejection were younger recipient age at transplant (aHR 0.98 per year increase, 95% CI: 0.97-1.00, p =0.01), and ABO-incompatible grafts (aHR 2.55 vs. ABO-compatible, 95% CI: 1.27-5.09, p <0.01) while simultaneous multiorgan transplants were protective (aHR 0.21 vs. LT only, 95% CI: 0.08-0.58, p <0.01). Development of acute rejection (both early and late) was independently associated with significantly reduced graft (aHR 3.13, 95% CI: 2.21-4.42, p <0.001) and patient survival (aHR 3.42, 95% CI: 2.35-4.98, p <0.001). In this 11-year Australian study, acute LT rejection occurred in 35%, with independent risk factors of younger recipient age and ABO-incompatible transplant, while having a simultaneous multiorgan transplant was protective. Acute rejection was independently associated with reduced graft and patient survival after adjustment for other factors.</p>","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"1039-1049"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140865899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2024-10-01Epub Date: 2024-04-23DOI: 10.1097/LVT.0000000000000377
Alan L Hutchison, K Gautham Reddy, Sonali Paul, Anjana A Pillai
{"title":"Geographic opportunities for growth in the transplant hepatology training workforce.","authors":"Alan L Hutchison, K Gautham Reddy, Sonali Paul, Anjana A Pillai","doi":"10.1097/LVT.0000000000000377","DOIUrl":"10.1097/LVT.0000000000000377","url":null,"abstract":"","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"1091-1094"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2024-10-01Epub Date: 2024-05-29DOI: 10.1097/LVT.0000000000000411
Abhilash Koratala, Kevin R Regner
{"title":"Letter to the Editor: Point-of-care ultrasound in cirrhosis-related acute kidney injury: A cautionary note.","authors":"Abhilash Koratala, Kevin R Regner","doi":"10.1097/LVT.0000000000000411","DOIUrl":"10.1097/LVT.0000000000000411","url":null,"abstract":"","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"E38-E39"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141427163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liver TransplantationPub Date : 2024-10-01Epub Date: 2024-03-27DOI: 10.1097/LVT.0000000000000369
Bradley Busebee, Kymberly D Watt, Kara Dupuy-McCauley, Hilary DuBrock
{"title":"Sleep disturbances in chronic liver disease.","authors":"Bradley Busebee, Kymberly D Watt, Kara Dupuy-McCauley, Hilary DuBrock","doi":"10.1097/LVT.0000000000000369","DOIUrl":"10.1097/LVT.0000000000000369","url":null,"abstract":"<p><p>Sleep disturbances are common in chronic liver disease and significantly impact patient outcomes and quality of life. The severity and nature of sleep disturbances vary by liver disease etiology and severity. While there is ongoing research into the association between liver disease and sleep-wake dysfunction, the underlying pathophysiology varies and, in many cases, is poorly understood. Liver disease is associated with alterations in thermoregulation, inflammation, and physical activity, and is associated with disease-specific complications, such as HE, that may directly affect sleep. In this article, we review the relevant pathophysiologic processes, disease-specific sleep-wake disturbances, and clinical management of CLD-associated sleep-wake disturbances.</p>","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":"1058-1071"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140293922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Roberta Angelico, Eliano Bonaccorsi Riani, Eleonora De Martin, Alessandro Parente, Maxime Foguenne, Bruno Sensi, Manuel L Rodríguez-Perálvarez
{"title":"Immunosuppression protocols for emerging oncological indications in liver transplantation: A systematic review and pooled analysis.","authors":"Roberta Angelico, Eliano Bonaccorsi Riani, Eleonora De Martin, Alessandro Parente, Maxime Foguenne, Bruno Sensi, Manuel L Rodríguez-Perálvarez","doi":"10.1097/LVT.0000000000000499","DOIUrl":"10.1097/LVT.0000000000000499","url":null,"abstract":"<p><p>The evolving field of liver transplant (LT) oncology calls for tailored immunosuppression protocols to minimize the risk of tumor recurrence. We systematically reviewed the available evidence from inception to May 2023 regarding immunosuppression protocols used in patients undergoing LT for cholangiocarcinoma, neuroendocrine tumors (NET), hepatic-endothelial hemangioendothelioma, and colorectal liver metastases (CRLM) to identify common practices and to evaluate their association with oncological outcomes. Studies not involving humans, case reports, and short case series (ie, n < 10) were excluded. Among 3374 screened references, we included 117 studies involving 6797 patients distributed as follows: cholangiocarcinoma (58.1%), NETs (18.8%), hepatic-endothelial hemangioendothelioma (7.7%), CRLM (6.8%), mixed neoplasms (6.8%), or others (1.7%). Only 41% of the studies disclosed details of the immunosuppression protocol, and 20.8% of studies provided drug trough concentrations during follow-up. The immunosuppression protocols described were heterogeneous and broadly mirrored routine practices for nontumoral indications. The only exception was CRLM, where tacrolimus minimization-or even withdrawal-in combination with inhibitors of the mammalian target of rapamycin (mTORi) were consistently reported. None of the studies evaluated the relationship between the immunosuppression protocol and oncological outcomes. In conclusion, based on low-quality and indirect scientific evidence, patients with tumoral indications for LT should receive the lowest tacrolimus level tolerated under close surveillance. The combination with mTORi titrated to achieve the top therapeutic range of trough concentrations could allow complete tacrolimus withdrawal. This approach may be particularly useful in patients with cholangiocarcinoma and CRLM, in whom tumor recurrence is the main cause of death. We propose a tool for reporting immunosuppression protocols, which could be implemented in future transplant oncology studies.</p>","PeriodicalId":18072,"journal":{"name":"Liver Transplantation","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142349433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}